Hjem › Diffust intrinsisk pontint gliom › Pennsylvania
Kliniske studier for Diffust intrinsisk pontint gliom i Pennsylvania
12 studier for Diffust intrinsisk pontint gliom søker deltakere på steder i Pennsylvania.
Byer i Pennsylvania
Offisiell studietekst (engelsk)
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Children's Hospital of Philidelphia, Philidelphia
RekruttererFase 2
12 Months – 39 Years · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06838676CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
RekruttererFase 1/2
12 Months – 21 Years · Alle kjønn · Oppdatert 11. sep. 2026 · NCT04870944Targeted Pediatric High-Grade Glioma Therapy
- Children's Hospital of Philadelphia, Philadelphia
RekruttererObservasjonsstudie
12 Months – 39 Years · Alle kjønn · Oppdatert 8. sep. 2026 · NCT05839379Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
RekruttererFase 1/2
Opp til 26 år · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06465199Study of Olutasidenib and Temozolomide in HGG
- Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 2
Alder 12 til 39 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06161974PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 2
Alder 3 til 39 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05096481Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 2
Alder 1 til 26 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT07680439Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
- Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 1/2
Alder 4 til 39 · Alle kjønn · Oppdatert 20. jul. 2026 · NCT05278208Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Children's Hospital of Philadelphia, Philadelphia
RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
Alder 1 til 21 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT06333899Combination Therapy for the Treatment of Diffuse Midline Gliomas
- Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 2
Alder 2 til 39 · Alle kjønn · Oppdatert 26. jun. 2026 · NCT05009992Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 2
12 Months – 39 Years · Alle kjønn · Oppdatert 29. mai 2026 · NCT05843253A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Children's Hospital of Philadelphia, Philadelphia
RekruttererTidlig fase 1
Opp til 21 år · Alle kjønn · Oppdatert 18. mar. 2026 · NCT04655404Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.